Litigation Risks Associated with AI in Healthcare

27 Jun , 2022

To register for the upcoming live webinar, please Click Here

With spending on the use of Artificial Intelligence (AI) in healthcare anticipated to skyrocket in the next two years, healthcare professionals, counsel and claims professionals need to prepare themselves now for the medicolegal issues that are coming. 

This lecture will focus on how AI is being used in medicine and its anticipated negative consequences, including new medical professional liability risks and discovery issues. The program is designed to educate, inform and enlighten those in healthcare risk management, claims management and information technology about the next revolution in healthcare: the use of AI in medical decision-making.

 

To register for the upcoming live webinar, please Click Here

More Webcasts

Who is Your Lawyer o...

Recent court opinions, a lawsuit against OpenAI Foundation and OpenAI Group PBC aka ChatGPT for the ...

Leaving Government E...

The program will cover the key issues for lawyer leaving government employment including the nuances...

Reinventing Project ...

The landscape of global finance is undergoing a seismic shift as traditional assets migrate to the b...

The AI Blind Spot in...

Many solo and small law firms assume AI governance is something only large firms need. It is not. AI...

Law in the Age of La...

Large World Models (LWMs)— the next generation of AI systems   capable of generating...

The Practical Lawyer...

Review the basic software concepts and effective uses of generative AI, prompting strategies, and me...

Complying with the M...

This course will provide a detailed overview of the Medicare Secondary Payer act as well as provide ...

Complying with the M...

This course will provide a detailed overview of the Medicare Secondary Payer act as well as provide ...

Freediving Through F...

Most legal professionals are operating in survival mode whether they realize it or not. Not crisis-l...

Appreciating 340B Dr...

Established in 1992, the 340B Drug Pricing Program has many nuances and applications to different si...